[27] [7] Patients should report any suspected side effects via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk)
Most claims are based on lab data, not real clinical trials with humans
The dual-action hormone mechanism Tirzepatide is a unique medication because it is a dual receptor agonist, meaning it mimics the action of two different natural hormones in your body: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)
However, the use of Semaglutide in certain populations requires caution
The active compound is absorbed through the mucous membranes of the mouth directly into the bloodstream, activating both GLP-1 and GIP receptors to reduce appetite, regulate blood sugar, and support sustained weight loss
This product is not known to produce negative side effects, however should you experience negative side effects then discontinue use